CTOs on the Move

OMNIlife science, Inc. (Main)

www.omnils.com

 
OMNIlife science, Inc. (Main) is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.omnils.com
  • 50 Oconnell Way
    East Taunton, MA USA '02718
  • Phone: 508.824.2444

Executives

Name Title Contact Details

Similar Companies

Vision Sciences, Inc.

Vision Sciences, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Decision Services

Medical Decision Services is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ANATOMICA AB

ANATOMICA AB is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Surgalign

Surgalign Holdings, Inc. is a global medical technology company committed to the promise of digital health to drive transformation across the surgical landscape. Uniquely aligned and resourced to advance the standard of care, the company is building technologies physicians and other health providers will look to for what is truly possible for their patients. Surgalign is focused on developing solutions that predictably deliver superior clinical and economic outcomes. Surgalign markets products throughout the United States and in approximately 50 countries worldwide through an expanding network of top independent distributors. Surgalign is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Warsaw and Poznan, Poland and Wurmlingen, Germany.

Avenda Health

Avenda Health is creating a more personalized future of prostate cancer care. Using deep learning, Avenda Health software maps a patient`s cancer in 3D, giving physicians precise information and the confidence to make care decisions. Dedicated to bringing this cutting-edge technology to all practices and physicians treating prostate cancer patients, Avenda Health aims to improve outcomes, preserve quality of life, and create a new standard of cancer care.